Optical Interventions for Myopia Control

Wing C Tang, Myra Leung, Angel C K Wong, Chi-ho To, Carly S Y Lam

Research output: A Conference proceeding or a Chapter in BookChapter

1 Downloads (Pure)

Abstract

Myopia is a common eye problem that is becoming more prevalent worldwide, particularly in East Asia. The cost of long-term care for myopia-related eye diseases significantly impacts the respective economies and places a great burden on the public health services. There is no doubt that myopia is a major East Asian public health concern and a significant concern globally, and effective control of myopia would help to alleviate the costs that are related to this problem. Currently, there are many types of optical interventions involving the use of spectacle lenses or contact lenses to slow down myopia progression in children. However, none of these myopia control methods have been proven to stop the development or progression of myopia completely and each method has their own limitations. Orthokeratology, soft bifocal contact lenses, prismatic bifocals, and myopic defocus incorporated spectacle lenses have all been shown to have clinically meaningful reductions in myopia progression ranging from 45% to 60%. Although pharmaceutical agents such as atropine have relatively better myopia control effects than optical methods, the associated side effects and uncertainty in the safety of long-term atropine use may hinder its widespread clinical application. Optical interventions are non-invasive and have become more popular compared to pharmaceutical treatments. This chapter provides an overview of the optical interventions for slowing myopia progression and their effectiveness in myopia control. Other myopia control methods will also be discussed briefly.
Original languageEnglish
Title of host publicationUpdates on Myopia
Subtitle of host publicationA Clinical Perspective
EditorsMarcus Ang, Tien Y Wong
Place of PublicationSingapore, Singapore
PublisherSpringer
Chapter14
Pages289-305
Number of pages17
ISBN (Electronic)9789811384912
ISBN (Print)9789811384905
DOIs
Publication statusPublished - 2020
Externally publishedYes

Publication series

NameUpdates on Myopia

Fingerprint

Myopia
Atropine
Lenses
Hydrophilic Contact Lens
Costs and Cost Analysis
United States Public Health Service
Far East
Eye Diseases
Contact Lenses
Long-Term Care
Pharmaceutical Preparations
Uncertainty
Public Health

Cite this

Tang, W. C., Leung, M., Wong, A. C. K., To, C., & Lam, C. S. Y. (2020). Optical Interventions for Myopia Control. In M. Ang, & T. Y. Wong (Eds.), Updates on Myopia: A Clinical Perspective (pp. 289-305). (Updates on Myopia). Singapore, Singapore: Springer. https://doi.org/10.1007/978-981-13-8491-2_14
Tang, Wing C ; Leung, Myra ; Wong, Angel C K ; To, Chi-ho ; Lam, Carly S Y. / Optical Interventions for Myopia Control. Updates on Myopia: A Clinical Perspective. editor / Marcus Ang ; Tien Y Wong. Singapore, Singapore : Springer, 2020. pp. 289-305 (Updates on Myopia).
@inbook{d9099fb1377c4de59b728677ba2e883a,
title = "Optical Interventions for Myopia Control",
abstract = "Myopia is a common eye problem that is becoming more prevalent worldwide, particularly in East Asia. The cost of long-term care for myopia-related eye diseases significantly impacts the respective economies and places a great burden on the public health services. There is no doubt that myopia is a major East Asian public health concern and a significant concern globally, and effective control of myopia would help to alleviate the costs that are related to this problem. Currently, there are many types of optical interventions involving the use of spectacle lenses or contact lenses to slow down myopia progression in children. However, none of these myopia control methods have been proven to stop the development or progression of myopia completely and each method has their own limitations. Orthokeratology, soft bifocal contact lenses, prismatic bifocals, and myopic defocus incorporated spectacle lenses have all been shown to have clinically meaningful reductions in myopia progression ranging from 45{\%} to 60{\%}. Although pharmaceutical agents such as atropine have relatively better myopia control effects than optical methods, the associated side effects and uncertainty in the safety of long-term atropine use may hinder its widespread clinical application. Optical interventions are non-invasive and have become more popular compared to pharmaceutical treatments. This chapter provides an overview of the optical interventions for slowing myopia progression and their effectiveness in myopia control. Other myopia control methods will also be discussed briefly.",
author = "Tang, {Wing C} and Myra Leung and Wong, {Angel C K} and Chi-ho To and Lam, {Carly S Y}",
year = "2020",
doi = "10.1007/978-981-13-8491-2_14",
language = "English",
isbn = "9789811384905",
series = "Updates on Myopia",
publisher = "Springer",
pages = "289--305",
editor = "Marcus Ang and Wong, {Tien Y}",
booktitle = "Updates on Myopia",
address = "Netherlands",

}

Tang, WC, Leung, M, Wong, ACK, To, C & Lam, CSY 2020, Optical Interventions for Myopia Control. in M Ang & TY Wong (eds), Updates on Myopia: A Clinical Perspective. Updates on Myopia, Springer, Singapore, Singapore, pp. 289-305. https://doi.org/10.1007/978-981-13-8491-2_14

Optical Interventions for Myopia Control. / Tang, Wing C; Leung, Myra; Wong, Angel C K; To, Chi-ho; Lam, Carly S Y.

Updates on Myopia: A Clinical Perspective. ed. / Marcus Ang; Tien Y Wong. Singapore, Singapore : Springer, 2020. p. 289-305 (Updates on Myopia).

Research output: A Conference proceeding or a Chapter in BookChapter

TY - CHAP

T1 - Optical Interventions for Myopia Control

AU - Tang, Wing C

AU - Leung, Myra

AU - Wong, Angel C K

AU - To, Chi-ho

AU - Lam, Carly S Y

PY - 2020

Y1 - 2020

N2 - Myopia is a common eye problem that is becoming more prevalent worldwide, particularly in East Asia. The cost of long-term care for myopia-related eye diseases significantly impacts the respective economies and places a great burden on the public health services. There is no doubt that myopia is a major East Asian public health concern and a significant concern globally, and effective control of myopia would help to alleviate the costs that are related to this problem. Currently, there are many types of optical interventions involving the use of spectacle lenses or contact lenses to slow down myopia progression in children. However, none of these myopia control methods have been proven to stop the development or progression of myopia completely and each method has their own limitations. Orthokeratology, soft bifocal contact lenses, prismatic bifocals, and myopic defocus incorporated spectacle lenses have all been shown to have clinically meaningful reductions in myopia progression ranging from 45% to 60%. Although pharmaceutical agents such as atropine have relatively better myopia control effects than optical methods, the associated side effects and uncertainty in the safety of long-term atropine use may hinder its widespread clinical application. Optical interventions are non-invasive and have become more popular compared to pharmaceutical treatments. This chapter provides an overview of the optical interventions for slowing myopia progression and their effectiveness in myopia control. Other myopia control methods will also be discussed briefly.

AB - Myopia is a common eye problem that is becoming more prevalent worldwide, particularly in East Asia. The cost of long-term care for myopia-related eye diseases significantly impacts the respective economies and places a great burden on the public health services. There is no doubt that myopia is a major East Asian public health concern and a significant concern globally, and effective control of myopia would help to alleviate the costs that are related to this problem. Currently, there are many types of optical interventions involving the use of spectacle lenses or contact lenses to slow down myopia progression in children. However, none of these myopia control methods have been proven to stop the development or progression of myopia completely and each method has their own limitations. Orthokeratology, soft bifocal contact lenses, prismatic bifocals, and myopic defocus incorporated spectacle lenses have all been shown to have clinically meaningful reductions in myopia progression ranging from 45% to 60%. Although pharmaceutical agents such as atropine have relatively better myopia control effects than optical methods, the associated side effects and uncertainty in the safety of long-term atropine use may hinder its widespread clinical application. Optical interventions are non-invasive and have become more popular compared to pharmaceutical treatments. This chapter provides an overview of the optical interventions for slowing myopia progression and their effectiveness in myopia control. Other myopia control methods will also be discussed briefly.

UR - http://www.mendeley.com/research/optical-interventions-myopia-control

U2 - 10.1007/978-981-13-8491-2_14

DO - 10.1007/978-981-13-8491-2_14

M3 - Chapter

SN - 9789811384905

T3 - Updates on Myopia

SP - 289

EP - 305

BT - Updates on Myopia

A2 - Ang, Marcus

A2 - Wong, Tien Y

PB - Springer

CY - Singapore, Singapore

ER -

Tang WC, Leung M, Wong ACK, To C, Lam CSY. Optical Interventions for Myopia Control. In Ang M, Wong TY, editors, Updates on Myopia: A Clinical Perspective. Singapore, Singapore: Springer. 2020. p. 289-305. (Updates on Myopia). https://doi.org/10.1007/978-981-13-8491-2_14